Point-of-Care Diagnostics Market

Roche (Switzerland) and Medtronic (Ireland) are the Key Players in the Point-of-Care/Rapid Diagnostics Market

The global point-of-care diagnostics market is estimated to be valued at USD 23.7 billion in 2017 and is projected to reach USD 38.1 billion by 2022 growing at a CAGR of 10.0%. The factors driving the growth of this market include high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and increasing inclination toward home healthcare across the globe.

Analysis of the market developments between 2015 and 2017 revealed that several growth strategies such as product launches, product approvals, acquisitions, collaborations, and expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the point-of-care diagnostics market. Among these business strategies, product approvals and launches were the most widely adopted growth strategies by players to garner a larger share of the market and remain competitive.

To know about the assumptions considered for the study download the pdf brochure

Roche (Switzerland) held the leadership position in the global point-of-care diagnostics market in 2016. The company has been focusing on the development of new products and technologies in the field of diagnostics. Through this, it introduced innovative products in the market, which enabled it to garner a higher market share. In addition, the company has a strong global presence with manufacturing facilities in Europe and the US and strong distribution channels to serve markets in Europe, the Middle East, Africa, Asia Pacific, and Latin and North America.

Abbott (US) held the second position in the global point-of-care diagnostics market in 2016. The company has a diversified portfolio, which includes a wide range of diagnostics tests, immunoassays, integrated systems, antibodies, fluorescent in situ hybridization (FISH) kits, and antibodies. The company’s key strategy is to focus on product launches, approvals, agreements, and collaborations to strengthen its portfolio and enhance its share in the global point-of-care diagnostics market. For instance, in November 2016, the company launched its i-Stat alinity system, a handheld device for blood testing.

Related Reports:

Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Report Code
MD 2702
RI Published ON
2/19/2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Point-of-Care Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved